ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESI....FIRO..CY..TRBGCZEE....SK....................................*JDIM360 Ver 2.15 (14 Jul 2008) - 2999001/01420827CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120091223W184deBibliographieenBibliographyfrBibliographieEP02794796.9200208162004031720061031enenen313048 P20010817US2009122320095220040526200422200909232009392009033020091223200952A61K 47/18 20060101AFI20030305BHEP A61K 38/29 20060101ALI20030305BHEP A61P 19/08 20060101ALI20030305BHEP A61P 19/10 20060101ALI20030305BHEP de5-CNAC ZUR ORALEN VERABREICHUNG VON PARATHORMONFRAGMENTENen5-CNAC AS ORAL DELIVERY AGENT FOR PARATHYROID HORMONE FRAGMENTSfr5-CNAC UTILISE EN TANT QU'AGENT D'ADMINISTRATION PAR VOIE ORALE POUR DES FRAGMENTS D'HORMONE PARATHYROIDIENNEWO-A-00/59863WO-A-94/07514US-A- 5 773 647LEONE-BAY A ET AL: "ORAL DELIVERY OF BIOLOGICALLY ACTIVE PARATHYROID HORMONE" PHARMACEUTICAL RESEARCH, NEW YORK, NY, US, vol. 18, no. 7, July 2001 (2001-07), pages 964-970, XP001106035 ISSN: 0724-8741LEONE-BAY A ET AL: "SYNTHESIS AND EVALUATION OF COMPOUNDS THAT FACILITATE THE GASTROINTESTINAL ABSORPTION OF HEPARIN" JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 41, no. 7, 26 March 1998 (1998-03-26), pages 1163-1171, XP001018961 ISSN: 0022-2623AZRIA, MoiseBundesplatz 6CH-4054 BaselCHBATEMAN, Simon, David4 Farrington LaneRandolph, NJ 07869USNovartis AG022404294-32113A/USNLichtstrasse 354056 BaselCHBEBGCHCYCZDEDKEEESFIFRGBGRIEITLILUMCNLPTSESKTRNovartis Pharma GmbH042736104-32113A/USNBrunner Strasse 591230 WienATATde Weerd, Petrus G.W.et al09391961c/o Novartis AG, Geistiges Eigentum Konzern CH4002 BaselCHATBEBGCHCYCZDEDKEEESFIFRGBGRIEITLILUMCNLPTSESKTRRO20040317SI20040317EP200200918120020816enWO20030158222003022720030920040526200422